MRI screening to find liver metastases in bowel cancer
Part of Cancer, Digestive system clinical trials.
This study checks whether a special MRI scan (DW-MRI) can spot liver metastases early in people with high-risk colorectal cancer. Finding metastases sooner may help doctors choose the right treatment path.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-risk colorectal (bowel) cancer
- Your CT scan did not show clear liver metastases (or did not confirm them)
- You can get the required treatment if liver metastases are found
- You are 16 years or older
- You can safely have an MRI scan
- You can sign a consent form to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to better plan “curative” treatment (aimed at cure) for sigmoid colon cancer before surgery. It is for people who may still be deciding on the radical (major, curative) treatment plan and who can safely have an MRI.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
This study uses a special MRI scan to see how colorectal cancer in the liver responds to planned chemotherapy before and after surgery. It may help doctors better measure treatment success and plan care.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
This trial uses MRI scans to study how colorectal cancer that has spread to the liver grows. It may help doctors choose better treatments.
This trial tests a new way to use MRI scans to better evaluate liver metastases in colorectal cancer. It may help doctors understand how tumors respond to chemotherapy.
Hear when a new Neoplasm Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.